Massachusetts-based Moderna will likely be the first to manufacture a bird flu vaccine, backed by hundreds of millions in government funding. The biopharmaceutical giant is developing the vaccine as a ...

Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains with pandemic potential.

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.

Another late-2024 study found that viral shedding, the expulsion of viral particles, in the air related to transmissibility ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Moderna led S&P 500 gainers Tuesday, a day after the first bird-flu death was reported in the U.S. The biotech company is developing a vaccine for H5N1.

Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of ...

Concerns about bird flu are growing among health officials weeks after the first person in the U.S. died from the virus, and ...